prikaz prve stranice dokumenta The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration
  Download
PDF 179.84 KB
Scientific paper - Review paper
The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration
GMS health innovation and technologies, 16 (2022); Doc04. https://doi.org/10.3205/hta000136
Bedlington, Nicole; Abifadel, Marianne; Beger, Birgit; Bourbon, Mafalda; Bueno, Héctor; Ceska, Richard; Cillíková, Kristýna; Cimická, Zdenka; Daccord, Magdalena; de Beaufort, Carine; Dharmayat, Kanika I.; Ference, Brian A.; Freiberger, Tomáš; Geanta, Marius; Gidding, Samuel S.; Grošelj, Urh; Halle, Martin; Johnson, Neil; Novaković, Tanja; Májek, Ondrej; Pallidis, Athanasios; Peretti, Noel; Pinto, Fausto J.; Ray, Kausik Kosh; Rees, Bleddyn; Reeve, John; Reiner, Željko; Santos, Raul D.; Schunkert, Heribert; Šikonja, Jaka; Sokolovic, Milka; Tokgözoglu, Lale; Vrablík, Michal; Wiegman, Albert; Gutiérrez-Ibarluzea, Iñaki More authors...

Cite this document

Bedlington, N., Abifadel, M., Beger, B., Bourbon, M., Bueno, H., Ceska, R. ... Gutiérrez Ibarluzea, I. (2022). The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration. GMS health innovation and technologies, 16.. doi: 10.3205/hta000136

Bedlington, Nicole, et al. "The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration." GMS health innovation and technologies, vol. 16, 2022. https://doi.org/10.3205/hta000136

Bedlington, Nicole, Marianne Abifadel, Birgit Beger, Mafalda Bourbon, Héctor Bueno, Richard Ceska, Kristýna Cillíková, et al. "The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration." GMS health innovation and technologies 16 (2022). https://doi.org/10.3205/hta000136

Bedlington, N., et al. (2022) 'The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration', GMS health innovation and technologies, 16. doi: 10.3205/hta000136

Bedlington N, Abifadel M, Beger B, Bourbon M, Bueno H, Ceska R, and sur.. The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration. GMS health innovation and technologies [Internet]. 2022 September 30 [cited 2024 October 06];16. doi: 10.3205/hta000136

N. Bedlington, et al., "The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration", GMS health innovation and technologies, vol. 16, September 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:371865. [Accessed: 06 October 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration
AuthorNicole Bedlington
AuthorMarianne Abifadel
AuthorBirgit Beger
AuthorMafalda Bourbon
AuthorHéctor Bueno
AuthorRichard Ceska
AuthorKristýna Cillíková
AuthorZdenka Cimická
AuthorMagdalena Daccord
AuthorCarine de Beaufort
AuthorKanika I. Dharmayat
AuthorBrian A. Ference
AuthorTomáš Freiberger
AuthorMarius Geanta
AuthorSamuel S. Gidding
AuthorUrh Grošelj
AuthorMartin Halle
AuthorNeil Johnson
AuthorTanja Novaković
AuthorOndrej Májek
AuthorAthanasios Pallidis
AuthorNoel Peretti
AuthorFausto J. Pinto
AuthorKausik Kosh Ray
AuthorBleddyn Rees
AuthorJohn Reeve
AuthorŽeljko Reiner
AuthorRaul D. Santos
AuthorHeribert Schunkert
AuthorJaka Šikonja
AuthorMilka Sokolovic
AuthorLale Tokgözoglu
AuthorMichal Vrablík
AuthorAlbert Wiegman
AuthorIñaki Gutiérrez-Ibarluzea
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Familial hypercholesterolaemia (FH) is the most common inherited metabolic disorder characterized by high cholesterol and if left untreated leads to premature cardiovascular disease, such as heart attacks. Treatment that begins early in life, particularly in childhood, is highly efficacious in preventing cardiovascular disease and cost-effective, thus early detection of FH is crucial. However, in Europe, less than 10% of people living with FH are diagnosed and even less receive life-saving treatment. The Prague Declaration is a call to action for national and European Union policymakers and decision-makers and a result of the Czech EU Presidency meeting on FH Paediatric Screening (early detection of inherited high cholesterol) at the Czech Senate in Prague on 6th September 2022. It builds on a considerable body of evidence which was discussed at the Technical Meeting under the auspices of the Slovenian EU Presidency in October 2021. The Prague meeting addressed the outstanding barriers to the systematic implementation of FH paediatric screening across Europe. In this article, we present the key points from the Prague meeting and concrete actions needed to move forward.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleGMS health innovation and technologies
Numberingvol. 16, Doc04
e-ISSN2698-6388
DOIhttps://doi.org/10.3205/hta000136
URN:NBNurn:nbn:hr:105:371865
Publication2022-09-30
Document URLhttps://www.egms.de/static/en/journals/hta/2022-16/hta000136.shtml
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2023-08-17 11:28:57